# BioReason-Pro RL Review: MYC (human)

Source: MYC-deep-research-bioreason-rl.md

- **Correctness**: 4/5
- **Completeness**: 3/5

The BioReason-Pro RL analysis of MYC is quite accurate, benefiting from the fact that MYC's function is tightly coupled to its bHLH-LZ domain architecture. The system correctly identifies MYC as a nuclear transcription factor that dimerizes via a leucine zipper and binds E-box DNA motifs to regulate cell proliferation.

**What it got right:**
- Correct identification of the N-terminal transactivation domain and C-terminal bHLH-LZ DNA-binding/dimerization module
- Accurate prediction of E-box (CACGTG) binding specificity
- Correct assignment of DNA-binding transcription factor activity
- Protein dimerization activity correctly predicted from the leucine zipper
- Nuclear localization correctly inferred
- Transcriptional regulation of cell proliferation and cell cycle as biological processes
- Recognition that the N-terminal domain recruits co-activators (including histone acetyltransferases)
- The mechanistic model of dimerization at E-box promoters followed by co-regulator recruitment is accurate

**What it missed or got incomplete:**
- No mention of MAX as the obligate heterodimerization partner. The analysis correctly predicts dimerization but does not identify the specific partner. The curated review explicitly identifies MYC-MAX heterodimerization as essential.
- No mention of transcriptional repression via MIZ1 (ZBTB17) interaction -- MYC is not only an activator
- No mention of the phosphodegron (T58/S62) and FBXW7-mediated proteasomal degradation, which is critical for MYC regulation
- No mention of Myc boxes (MBI-MBIV) as conserved functional elements within the N-terminal domain
- No mention of MYC as a proto-oncogene deregulated in >50% of cancers
- No discussion of ribosome biogenesis as a major MYC target program -- the curated review notes MYC regulates approximately 11% of human genes
- No mention of apoptotic functions (MYC promotes apoptosis under certain conditions)
- No mention of chromatin remodeling, which is covered in the curated GO annotations

**Failure modes observed:**
- The analysis is structurally sound but generic. "A nuclear transcriptional regulator that binds E-box DNA elements as a dimer" could describe any bHLH-LZ factor -- it does not capture what makes MYC specifically important
- The prediction that MYC drives "proliferative transcriptional programs" is correct but could be said of many oncogenic transcription factors

This is one of the better BioReason predictions because the bHLH-LZ architecture is highly predictive of function. The core molecular function and process assignments are accurate, though the analysis lacks the biological depth found in the curated review.
